The Oncologic Value of Transoral Resection in Early-Stage Laryngeal Squamous Cell Carcinoma of the Glottis: A Retrospective Study
- PMID: 39449894
- PMCID: PMC11499731
- DOI: 10.7759/cureus.69975
The Oncologic Value of Transoral Resection in Early-Stage Laryngeal Squamous Cell Carcinoma of the Glottis: A Retrospective Study
Abstract
Background and objective The treatment of early-stage laryngeal glottic cancer involves surgery or radiotherapy, and both have similar survival rates. However, discrepancies between systematic reviews in the literature point towards the continuous need for more data. In this study, we aimed to investigate the oncologic value of surgery at an ENT university department of a tertiary hospital in Greece. Materials and methods Patients with T1 or T2 laryngeal squamous cell carcinoma of the glottis who underwent transoral tumor resection between April 2014 and September 2021 at the hospital were deemed eligible for this study. Disease-free survival (DFS), local control rate (LCR), overall survival (OS), and laryngeal preservation were assessed. Results We enrolled 43 subjects with a median age of 67 years (range: 46-84 years). An overwhelming majority of the subjects were men (39/43). The most common stage was T1a (22/43 subjects). OS was 74 months and DFS was 67 months. We noted local recurrence in 7/43 subjects. Three subjects passed away after five years of follow-up. Eventually, total laryngectomy was performed in 4/43 subjects, two of whom initially suffered from a T2 glottic carcinoma. Conclusions Our results align with the findings of the systematic reviews supporting high survival rates, laryngeal preservation, and avoidance of radiotherapy complications observed after transoral surgery for early-stage laryngeal glottic carcinoma.
Keywords: laryngeal neoplasms; laryngeal tumors; laser; prognosis; surgical managment.
Copyright © 2024, Ioannidis et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. IRB of General Hospital of Athens Hippokration issued approval N/A. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures


Similar articles
-
Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma.ANZ J Surg. 2012 Oct;82(10):720-3. doi: 10.1111/j.1445-2197.2012.06138.x. Epub 2012 Aug 20. ANZ J Surg. 2012. PMID: 22901105
-
Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.Head Neck. 1999 Dec;21(8):707-17. doi: 10.1002/(sici)1097-0347(199912)21:8<707::aid-hed5>3.3.co;2-u. Head Neck. 1999. PMID: 10562683
-
[Analysis of curative effect of transoral radiofrequency ablation microsurgery on glottic carcinoma with anterior commissure involvement at the early stage].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Feb 7;53(2):86-91. doi: 10.3760/cma.j.issn.1673-0860.2018.02.002. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018. PMID: 29429176 Chinese.
-
Systematic review and meta-analysis of T1 glottic cancer outcomes comparing CO2 transoral laser microsurgery and radiotherapy.J Otolaryngol Head Neck Surg. 2019 Sep 3;48(1):44. doi: 10.1186/s40463-019-0367-2. J Otolaryngol Head Neck Surg. 2019. PMID: 31481120 Free PMC article.
-
Contemporary Surgical Management of Early Glottic Cancer.Otolaryngol Clin North Am. 2015 Aug;48(4):611-25. doi: 10.1016/j.otc.2015.04.007. Otolaryngol Clin North Am. 2015. PMID: 26233790 Review.
Cited by
-
The impact of histopathology on prognosis of squamous cell carcinoma of the larynx: can we do better?Virchows Arch. 2025 Jul;487(1):13-32. doi: 10.1007/s00428-025-04082-w. Epub 2025 Mar 27. Virchows Arch. 2025. PMID: 40140089 Free PMC article. Review.
References
-
- T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. J Clin Oncol. 2001;19:4029–4036. - PubMed
-
- What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility? Higgins KM. Laryngoscope. 2011;121:116–134. - PubMed
-
- New AJCC/UICC staging system for head and neck, and thyroid cancer. Shah JP, Montero PH. Rev Méd Clín Las Condes. 2018;29:397–404.
-
- Transoral laser surgery versus radiotherapy for tumour stage 1a or 1b glottic squamous cell carcinoma: systematic review of local control outcomes. O'Hara J, Markey A, Homer JJ. J Laryngol Otol. 2013;127:732–738. - PubMed
-
- Treatment of early-stage laryngeal cancer: a comparison of treatment options. Baird BJ, Sung CK, Beadle BM, Divi V. Oral Oncol. 2018;87:8–16. - PubMed
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous